Immune cell profiling and antibody responses in patients with COVID-19

被引:16
|
作者
Rezaei, Mitra [1 ]
Mahmoudi, Shima [2 ]
Mortaz, Esmaeil [3 ]
Marjani, Majid [3 ]
机构
[1] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis NRITLD, Virol Res Ctr, Tehran, Iran
[2] Univ Tehran Med Sci, Childrens Med Ctr Hosp, Pediat Ctr Excellence, Pediat Infect Dis Res Ctr, Dr Gharib St,Keshavarz Blvd, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis NRITLD, Clin TB & Epidemiol Res Ctr, Tehran, Iran
关键词
SARS-CoV-2; COVID-19; Antibody response; Lymphocyte subsets;
D O I
10.1186/s12879-021-06278-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundAlthough there are a growing number of studies on evaluating lymphocyte subset counts as prognostic factors for COVID-19 disease severity, the lymphocyte subsets' analyses of both IgM and IgG responders and non-responders during the periods after onset of symptoms, have not been conducted yet. So, this study aimed to evaluate immune cell profiling of COVID-19 patients with and without antibody responses.MethodsIn this cross-sectional study, the levels of peripheral lymphocyte subsets were measured using flow cytometry in 53 patients with positive SARS-CoV-2 RT-PCR, for whom antibody testing of COVID-19 was performed.ResultsThe white blood cell, neutrophil, and lymphocyte counts consistently decreased in the IgM and IgG non-responder group, while the differences in the median value between the two study groups were found to be statistically significant only in terms of neutrophil counts (P=0.024 for IgM response and p-value= 0.046 for IgG response, respectively). Moreover, the level of neutrophil-to-lymphocyte ratio was observed to be significantly lower in the IgM or IgG non-responder group compared to the IgM or IgG responder group (3.63.1 vs. 6.3 +/- 4.2; p-value= 0.021). The patients with IgM antibody response had a significantly lower CD20(+) lymphocytes (11% versus 15% in the groups without IgM antibody response, p-value= 0.031), The percentages of NK cells and CD4(+) T cells significantly increased in the patients with IgG antibody response compared to those without IgG antibody response (13% versus 10%, p-value= 0.028, and 41.5% versus 34%; p-value= 0.03, respectively). Moreover, the patients who produced IgM or IgG antibody had significantly higher percentages of total T lymphocytes (64% versus 54%; p-value= 0.017), CD4(+) T cells (41% versus 34%; p-value=0.038), and NK cells (13% versus 9%, p-value=0.023) compared to the group with no serological response. No significant difference was observed in the percentage of other lymphocyte subsets, including CD8(+) T cells, T-reg cells, and CD19(+) B cells.Conclusion Our results suggest that the total T cells, CD4(+) T cells, and NK cells percentages are linked to serological response. Moreover, our findings suggested that neutrophil absolute counts and neutrophil-to-lymphocyte ratio may be valuable predictors of IgM or IgG antibody response.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] T cell responses in patients with COVID-19
    Zeyu Chen
    E. John Wherry
    Nature Reviews Immunology, 2020, 20 : 529 - 536
  • [22] T cell responses in patients with COVID-19
    Chen, Zeyu
    John Wherry, E.
    NATURE REVIEWS IMMUNOLOGY, 2020, 20 (09) : 529 - 536
  • [23] Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies
    Rouhani, Sherin Juliet
    Yu, Jovian
    Olson, Daniel
    Zha, Yuanyuan
    Pezeshk, Apameh
    Cabanov, Alexandra
    Pyzer, Athalia R.
    Trujillo, Jonathan
    Derman, Benjamin A.
    O'Donnell, Peter
    Jakubowiak, Andrzej
    Kindler, Hedy L.
    Bestvina, Christine
    Gajewski, Thomas F.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (06)
  • [24] Antibody Responses in COVID-19: A Review
    Chvatal-Medina, Mateo
    Mendez-Cortina, Yorjagis
    Patino, Pablo J.
    Velilla, Paula A.
    Rugeles, Maria T.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [25] Longitudinal dynamics of antibody responses in recovered COVID-19 patients
    Meng-Li Cheng
    Hui-Ying Liu
    Hui Zhao
    Guo-Qing Wang
    Chao Zhou
    Jing Zheng
    Xiao-Feng Li
    Fan Li
    Chang-Qing Bai
    Cheng-Feng Qin
    Signal Transduction and Targeted Therapy, 6
  • [26] Longitudinal dynamics of antibody responses in recovered COVID-19 patients
    Cheng, Meng-Li
    Liu, Hui-Ying
    Zhao, Hui
    Wang, Guo-Qing
    Zhou, Chao
    Zheng, Jing
    Li, Xiao-Feng
    Li, Fan
    Bai, Chang-Qing
    Qin, Cheng-Feng
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [27] Antibody Responses and the Effects of Clinical Drugs in COVID-19 Patients
    Wei, Liwen
    Shang, Yuqi
    Liu, Xi
    Li, Xinghua
    Chen, Gongqi
    Liang, Siping
    Zou, Zhengyu
    Ding, Tao
    Hong, Zhongsi
    Wu, Minhao
    Xia, Jinyu
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [28] Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients
    Suthar, Mehul S.
    Zimmerman, Matthew G.
    Kauffman, Robert C.
    Mantus, Grace
    Linderman, Susanne L.
    Hudson, William H.
    Vanderheiden, Abigail
    Nyhoff, Lindsay
    Davis, Carl W.
    Adekunle, Oluwaseyi
    Affer, Maurizio
    Sherman, Melanie
    Reynolds, Stacian
    Verkerke, Hans P.
    Alter, David N.
    Guarner, Jeannette
    Bryksin, Janetta
    Horwath, Michael C.
    Arthur, Connie M.
    Saakadze, Natia
    Smith, Geoffrey H.
    Edupuganti, Srilatha
    Scherer, Erin M.
    Hellmeister, Kieffer
    Cheng, Andrew
    Morales, Juliet A.
    Neish, Andrew S.
    Stowell, Sean R.
    Frank, Filipp
    Ortlund, Eric
    Anderson, Evan J.
    Menachery, Vineet D.
    Rouphael, Nadine
    Mehta, Aneesh K.
    Stephens, David S.
    Ahmed, Rafi
    Roback, John D.
    Wrammert, Jens
    CELL REPORTS MEDICINE, 2020, 1 (03)
  • [29] Cell-Mediated Immune Responses to COVID-19 Infection
    Guihot, Amelie
    Litvinova, Elena
    Autran, Brigitte
    Debre, Patrice
    Vieillard, Vincent
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [30] Cell specific peripheral immune responses predict survival in critical COVID-19 patients
    Junedh M. Amrute
    Alexandra M. Perry
    Gautam Anand
    Carlos Cruchaga
    Karl G. Hock
    Christopher W. Farnsworth
    Gwendalyn J. Randolph
    Kory J. Lavine
    Ashley L. Steed
    Nature Communications, 13